Cargando…

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894432/ https://www.ncbi.nlm.nih.gov/pubmed/24459637 http://dx.doi.org/10.3350/cmh.2013.19.4.325

Ejemplares similares

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021)

KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease
Publicado: (2013)

KASL clinical practice guidelines: Management of Hepatitis C
Publicado: (2014)

KASL clinical practice guidelines: management of hepatitis C
Publicado: (2016)

KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Publicado: (2012)

KASL clinical practice guidelines: management of chronic hepatitis B
Publicado: (2016)

KASL clinical practice guidelines for management of chronic hepatitis B
Publicado: (2019)

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Publicado: (2018)

KASL clinical practice guidelines for management of chronic hepatitis B
Publicado: (2022)

KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Publicado: (2023)

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Publicado: (2018)

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Publicado: (2020)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
por: Cho, Ju-Yeon, et al.
Publicado: (2021)

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]
Publicado: (2022)

Practical approaches to the nutritional management of nonalcoholic fatty liver disease
por: Freidoony, Leila, et al.
Publicado: (2014)

Management of nonalcoholic fatty liver disease in the Middle East
por: Sanai, Faisal M, et al.
Publicado: (2020)

Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease
por: Shrestha, Ananta, et al.
Publicado: (2022)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice
por: Nababan, Saut Horas H., et al.
Publicado: (2022)

CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE
por: Virović Jukić, Lucija, et al.
Publicado: (2021)

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
por: Yeon, Jong Eun
Publicado: (2018)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
por: Zhou, Jiang-Hua, et al.
Publicado: (2019)

Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach
por: Grgurevic, Ivica, et al.
Publicado: (2020)

Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
por: Attar, Bashar M., et al.
Publicado: (2013)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease
por: Vittorio, Jennifer, et al.
Publicado: (2020)

Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Chin, Kok-Yong, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g5uvjmmnjvcnk75pp7djbijf5q